Jiang, Yuxiong
Huang, Dawei
Chen, Qianyu
Yu, Yingyuan
Hu, Yifan
Wang, Yu
Chen, Rongfen
Yao, Lingling
Zhong, Xiaoyuan
Kong, Luyang
Yu, Qian
Lu, Jiajing
Li, Ying
Shi, Yuling
Clinical trials referenced in this document:
Documents that mention this clinical trial
A novel online calculator based on clinical features and hematological parameters to predict total skin clearance in patients with moderate to severe psoriasis
https://doi.org/10.1186/s12967-023-04847-4
The Impact of Family History on Clinical Presentation and Biologic Treatment Response in Patients with Psoriasis: A Multicenter Prospective Cohort Study
https://doi.org/10.1007/s40257-025-00918-y
Documents that mention this clinical trial
The association of premorbid conditions with 6-month mortality in acutely admitted ICU patients over 80 years
https://doi.org/10.1186/s13613-024-01246-w
Robot-assisted mobilisation in the intensive care unit: does it offer relief to mobilising specialists? A qualitative longitudinal study at a German university hospital
https://doi.org/10.1007/s44155-024-00074-4
A novel online calculator based on clinical features and hematological parameters to predict total skin clearance in patients with moderate to severe psoriasis
https://doi.org/10.1186/s12967-023-04847-4
Adverse events in India’s Ayush interventions for cervical and lumbar spondylosis: a systematic review
https://doi.org/10.1186/s40001-024-01985-3
Meta-analysis of three randomized trials of capecitabine plus cisplatin (XP) versus S-1 plus cisplatin (SP) as first-line treatment for advanced gastric cancer
https://doi.org/10.1007/s10147-023-02402-1
Documents that mention this clinical trial
The association of premorbid conditions with 6-month mortality in acutely admitted ICU patients over 80 years
https://doi.org/10.1186/s13613-024-01246-w
Robot-assisted mobilisation in the intensive care unit: does it offer relief to mobilising specialists? A qualitative longitudinal study at a German university hospital
https://doi.org/10.1007/s44155-024-00074-4
A novel online calculator based on clinical features and hematological parameters to predict total skin clearance in patients with moderate to severe psoriasis
https://doi.org/10.1186/s12967-023-04847-4
Adverse events in India’s Ayush interventions for cervical and lumbar spondylosis: a systematic review
https://doi.org/10.1186/s40001-024-01985-3
Meta-analysis of three randomized trials of capecitabine plus cisplatin (XP) versus S-1 plus cisplatin (SP) as first-line treatment for advanced gastric cancer
https://doi.org/10.1007/s10147-023-02402-1
HS-10375, a selective EGFR C797S tyrosine kinase inhibitor, in advanced non–small cell lung cancer
https://doi.org/10.1186/s12967-025-06613-0
Funding for this research was provided by:
National Natural Science Foundation of China (81872522, 82073429, 82203913)
Innovation Program of Shanghai Municipal Education Commission (2019-01-07-00-07-E00046)
Clinical Research Plan of SHDC (SHDC2020CR1014B)
Program of Shanghai Academic Research Leader (20XD1403300)
the Fundamental Research Funds for the Central Universities (22120220602)
Article History
Received: 26 October 2023
Accepted: 29 December 2023
First Online: 31 January 2024
Declarations
:
: This study protocol was reviewed and approved by the Medical Ethical Committee of Shanghai Skin Disease Hospital (approval #2020-36).
: Written informed consent was obtained from all participating patients.
: Not applicable.
: The authors have no competing interests to declare.